Abstract:Background: The aim of this study is to explore the pathogenic bacteria type, distribution, drug resistance and influencing factors of nosocomial pulmonary infection in patients with lung cancer during chemotherapy. Methods: This study retrospectively analyzed the clinical data of 411 patients with lung cancer who were hospitalized in the First Affiliated Hospital of Zhejiang University Medical College from January 2017 to December 2018, and counted the incidence of nosocomial lung infection, pathogens, drug resistance and influencing factors. Results: There were 184 cases of nosocomial pulmonary infection in 411 lung cancer patients during chemotherapy, the infection rate was 44.77%. The isolated pathogens included Gram-negative bacteria, Gram-positive bacteria, viruses, fungi and tuberculosis, among which Gram-negative bacteria accounted for 37.25%, followed by virus infection, accounting for 15.69%. Pseudomonas aeruginosa and Klebsiella pneumoniae are the main Gram-negative bacteria, Staphylococcus aureus and Streptococcus pneumoniae are the common gram-positive bacteria, influenza B virus is the main virus, Candida and Aspergillus are the most common fungi. The resistance rate of Pseudomonas aeruginosa to imipenem was 26.67%, while that of Klebsiella pneumoniae to imipenem was 12.50%, and that of the main Gram-positive bacteria to vancomycin was 0.00%. Hypoproteinemia, long chemotherapy cycle, high-intensity chemotherapy, chronic obstructive pulmonary disease and basic bronchiectasis were the high risk factors of lung cancer patients with nosocomial pulmonary infection during chemotherapy (P<0.05). Conclusions: During the chemotherapy of lung cancer patients with nosocomial pulmonary infection, the distribution and drug resistance of pathogenic bacteria have certain characteristics. Clinicians should strengthen the detection of pathogenic bacteria and their drug resistance. On the basis of symptomatic treatment, to achieve the purpose of ensuring the treatment effect and prolonging the survival period of patients, preventive measures should be taken for high-risk patients to reduce the chemotherapy cycle and intensity as much as possible to reduce the incidence of infection life.

Analysis of Common Microorganisms and Antibiotic Resistance of Nosocomial Bacterial Pneumonia in 179 Patients with Lung Cancer

[Following-Up of Nosocomial Lower Respiratory Infection in Patients with Hematological Malignancy after Chemotherapy].

Pathogenic Bacteria of Nosocomial Infection and Their Drug Resistance in Patients with Lung Cancer in Respiratory Intensive Care Unit

Clinical Analysis of 34 Cases of Lung Cancer Complicated with Hospital Acquired Pneumonia

Characterization of Antibiotic Resistance of Nosocomial Bacilli Infection in Cancer Patients

Analysis of drug-sensibility and pathogen variance of lower respiratory tract infection accompanying lung cancer

Resistance of the Carbapenems and Homology Analysis of Pseudomonas Aeruginosa in 28 Hospitals in China

ANALYSIS OF PATHOGENIC BACTERIA AND DRUG RESISTANCE OF RESPIRATORY INFECTION ON THE INTERMEDIATE-ADVANCED STAGE LUNG CANCER PATIENTS

Nosocomial Infections Due to Multidrug-Resistant Bacteria in Cancer Patients: a Six-Year Retrospective Study of an Oncology Center in Western China

Pathogens causing nosocomial infections in lung cancer patients treated with chemother-apy and drug susceptibility

Distribution of Pathogens in Patients with Malignant Tumor Combined Hospital-Acquired Pneumonia and Analysis of Drug Resistance

[Characteristics and Influencing Factors of Pathogenic Bacteria in Lung Cancer Chemotherapy Combined with Nosocomial Pulmonary Infection]

Distribution and antibiotic resistance of bacteria isolated from bloodstream infections in Beijing cancer Hospital

Analysis of distribution and resistance of 353 strains Pseudomonas aeruginosa in clinical infection

Bacterial Antibiotic Resistance among Cancer Inpatients in China: 2016-20

The pulmonary infection and drug resistance analysis of Klebsiella pneumoniae in hospitalized liver disease patients

Gram-negative bacteria for pulmonary infections in chronic obstructive pulmonary disease and drug resistance analysis

Analysis and of Bacteria Their Antibiotic Resistance in Lower Respiratory Infection

Drug resistance and prognosis of gram-negative bacilli isolated from nosocomial lower respiratory tract

Treatment of Community-Onset Pneumonia in Neutropenic Cancer Patients: Β-Lactam Monotherapy Versus Combination Antibiotic Regimens

Distribution and Drug Resistance of Klebsiella Pneumoniae and Acinetobacter Baumannii Causing Nosocomial Infections